Moreover, urea cycle enzymes (ASS1 and CPS1) are inhibited in liver cancer (Kim et al., 2021; Ridder et al., 2021), so the expression of them have decreased in liver cancer cells, and the increase of ASS1 and CPS1 caused by knocking down NFIB becomes insignificant. The gene discussed is ASS1; the disease is liver cancer.